Here's Why You Should Retain Exact Sciences (EXAS) Stock Now
https://www.zacks.com/stock/news/2197564/here-s-why-you-should-retain-exact-sciences-exas-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197564
Dec 13, 2023 - Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard adoption and raised guidance.
0
Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
https://www.zacks.com/stock/news/2226264/exact-sciences-exas-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2226264
Feb 14, 2024 - Exact Sciences (EXAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
https://www.zacks.com/stock/news/2227354/ironwood-irwd-q4-earnings-miss-revenues-beat-marginally?cid=CS-ZC-FT-analyst_blog|earnings_article-2227354
Feb 16, 2024 - Ironwood's (IRWD) fourth-quarter 2023 earnings lag estimates while revenues beat the same marginally. Linzess collaboration revenues drive the top line.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2245870/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245870
Mar 26, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
0
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
https://www.zacks.com/stock/news/2256957/abbott-abt-q1-earnings-beat-estimates-margins-contract?cid=CS-ZC-FT-analyst_blog|earnings_article-2256957
Apr 17, 2024 - Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
0
ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
https://www.zacks.com/stock/news/2257821/icon-iclr-gains-from-new-offerings-strategic-acquisitions?cid=CS-ZC-FT-analyst_blog|zer_report_update-2257821
Apr 18, 2024 - ICON (ICLR) continues to develop its collaboration and delivery models, invest in technology and enhance its project and program management capabilities.
0
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
https://www.zacks.com/stock/news/2262670/icon-iclr-q1-earnings-surpass-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2262670
Apr 25, 2024 - ICON's (ICLR) first-quarter 2024 performance is driven by its efficient service delivery and strong cost control.
0
Pages: 12
<Page 2